PTBP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.639000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.267600E-02
Normal-vs-Stage2
5.017300E-03
Normal-vs-Stage3
2.166100E-02
Normal-vs-Stage4
3.782300E-02
Stage1-vs-Stage2
2.263600E-01
Stage1-vs-Stage3
8.510300E-02
Stage1-vs-Stage4
3.184000E-01
Stage2-vs-Stage3
4.685400E-01
Stage2-vs-Stage4
9.028600E-01
Stage3-vs-Stage4
3.287000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.217900E-03
Normal-vs-AfricanAmerican
7.540500E-02
Normal-vs-Asian
1.086220E-01
Caucasian-vs-AfricanAmerican
7.749600E-01
Caucasian-vs-Asian
5.489800E-01
AfricanAmerican-vs-Asian
9.105200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.435500E-03
Normal-vs-Female
1.759810E-02
Male-vs-Female
1.284360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.081650E-01
Normal-vs-Age(41-60Yrs)
1.721750E-03
Normal-vs-Age(61-80Yrs)
1.214300E-02
Normal-vs-Age(81-100Yrs)
4.922200E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.559800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.867800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.396400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.337420E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.511230E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.148200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.239110E-03
Normal-vs-Daily Drinker
4.017400E-03
Normal-vs-Weekly Drinker
5.304000E-03
Normal-vs-Occasional Drinker
1.868210E-02
Normal-vs-Social Drinker
1.416370E-01
Non Drinker-vs-Daily Drinker
7.387000E-01
Non Drinker-vs-Weekly Drinker
7.031600E-01
Non Drinker-vs-Occasional Drinker
2.406200E-01
Non Drinker-vs-Social Drinker
2.699000E-01
Daily Drinker-vs-Weekly Drinker
5.416800E-01
Daily Drinker-vs-Occasional Drinker
4.264400E-01
Daily Drinker-vs-Social Drinker
3.743800E-01
Weekly Drinker-vs-Occasional Drinker
2.159000E-01
Weekly Drinker-vs-Social Drinker
2.220600E-01
Occasional Drinker-vs-Social Drinker
7.247200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.792200E-01
Normal-vs-Grade 2
1.493570E-01
Normal-vs-Grade 3
2.032000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.032800E-01
Grade 1-vs-Grade 3
2.839600E-01
Grade 1-vs-Grade 4
2.792200E-01
Grade 2-vs-Grade 3
1.702420E-01
Grade 2-vs-Grade 4
1.493570E-01
Grade 3-vs-Grade 4
2.032000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.655000E-03
Normal-vs-NonDiabetic
7.521900E-03
Diabetic-vs-NonDiabetic
2.297200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.538010E-01
Normal-vs-NoPancreatitis
2.096600E-03
Pancreatitis-vs-NoPancreatitis
6.546400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.039000E-03
Normal-vs-N1
6.120600E-03
N0-vs-N1
8.542800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.676190E-02
Normal-vs-TP53-NonMutant
4.208500E-02
TP53-Mutant-vs-TP53-NonMutant
1.897160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
